These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 11426647

  • 1. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J, Jove R.
    Oncogene; 2000 Dec 27; 19(56):6613-26. PubMed ID: 11426647
    [Abstract] [Full Text] [Related]

  • 2. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Buettner R, Mora LB, Jove R.
    Clin Cancer Res; 2002 Apr 27; 8(4):945-54. PubMed ID: 11948098
    [Abstract] [Full Text] [Related]

  • 3. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R.
    Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264
    [Abstract] [Full Text] [Related]

  • 4. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
    Xi S, Gooding WE, Grandis JR.
    Oncogene; 2005 Feb 03; 24(6):970-9. PubMed ID: 15592503
    [Abstract] [Full Text] [Related]

  • 5. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L, Turkson J, Karras JG, Jove R, Haura EB.
    Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
    Germain D, Frank DA.
    Clin Cancer Res; 2007 Oct 01; 13(19):5665-9. PubMed ID: 17908954
    [Abstract] [Full Text] [Related]

  • 15. STATs in oncogenesis.
    Bowman T, Garcia R, Turkson J, Jove R.
    Oncogene; 2000 May 15; 19(21):2474-88. PubMed ID: 10851046
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT, Wang S, Ye YJ, Du RY, Cui ZR.
    Ai Zheng; 2003 Nov 15; 22(11):1135-9. PubMed ID: 14613639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC, Luo RZ.
    Cancer Res; 2005 Aug 01; 65(15):6701-10. PubMed ID: 16061651
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.